Companies: 10,795·Total market cap: $144.5T
Dynavax Technologies Corporation

Dynavax Technologies Corporation

DVAXNASDAQHealthcare
$15.50
+$0.00(+0.00%)
Market Cap$1.8B
P/E Ratio—
52W High$15.73
52W Low$9.2
Shares OutstandingFinancialsRevenue

Dynavax Technologies Corporation (DVAX) Shares Outstanding — Overview

Basic and diluted weighted average shares, YoY change, float context, and historical trend from SEC filings and FMP.

DVAX · shares outstanding · updated Jun 8, 2026

Key metrics

Basic Shares Outstanding · Weighted average · fiscal year
130.0M▲ +1.02% YoY Change
FY · as of Dec 31, 2024 · Reported in USD
vs 128.7M in FY 2023
Diluted Shares Outstanding
133.3M
incl. options, RSUs, convertibles
Dilution Spread
+2.54%
Diluted vs Basic
YoY Change
+1.02%
year-over-year
Float (Free Float)
100.3M
publicly tradable shares
85.5% of total
Source: FMP /income-statement · /shares-float · SEC 10-K / 10-QUpdated: 2026-06-08

Shares Outstanding Growth Rate

3-Year CAGRincreasing
+3.8%
2021 → 2024
5-Year CAGRincreasing
+12.5%
2019 → 2024
10-Year CAGRincreasing
+17.3%
2014 → 2024
ⓘ

Negative CAGR typically indicates share buyback or retirement activity. Interpret alongside Splits and Financials tabs. Splits / Financials

Shares outstanding history

↓ Decrease — typically buyback / retirement
↑ Increase — issuance / equity compensation
Latest
* most recent reported · FMP /income-statement · weightedAverageShsOut

Annual shares outstanding by year

FY 2024Latest
Diluted Shares: 133.3M
130.0M
+1.02%
FY 2023
Diluted Shares: 128.7M
128.7M
+1.85%
FY 2022
Diluted Shares: 150.8M
126.4M
+8.72%
FY 2021
Diluted Shares: 133.0M
116.3M
+15.40%
FY 2020
Diluted Shares: 100.8M
100.8M
+39.89%
FMP /income-statement · weightedAverageShsOut · weightedAverageShsOutDilUnit: Billions (B)

Healthcare sector shares outstanding comparison

Shares Outstanding for similar companies or competitors in the Healthcare sector.

#SymbolCompanyShares (Basic)vs DVAX
#1
Merck & Co., Inc.MRK
Merck & Co., Inc.
2.502B+>999%
#2
Johnson & JohnsonJNJ
Johnson & Johnson
2.429B+>999%
#3
AbbVie Inc.ABBV
AbbVie Inc.
1.780B+>999%
#4
AstraZeneca PLCAZN
AstraZeneca PLC
1.550B+>999%
#5
UnitedHealth Group IncorporatedUNH
UnitedHealth Group Incorporated
910.0M+599.7%
#6
Eli Lilly and CompanyLLY
Eli Lilly and Company
898.0M+590.5%
#7
Dynavax Technologies CorporationDVAX
Dynavax Technologies CorporationYOU
130.0M—

/company-screener · per-peer /income-statement · cache 86400s

Understanding Shares Outstanding

What Are Shares Outstanding? (Basic)

Dynavax Technologies Corporation (DVAX) shares outstanding is the total number of issued shares held by shareholders — the basis for Basic EPS and market capitalization. As of December 31, 2024, Dynavax Technologies Corporation reports 130.0M basic shares outstanding (weighted average).

Basic vs. Diluted Shares Outstanding

Dynavax Technologies Corporation's basic shares outstanding (130.0M) represents currently issued shares. Diluted shares outstanding (133.3M) also includes potential shares from stock options, RSUs, and convertibles. Dilution spread: +2.54%.

Shares Outstanding vs. Float (Free Float)

Dynavax Technologies Corporation's float is 100.3M (85.5% of total shares outstanding) — shares freely available for public trading, excluding insider-held and restricted shares.

Float100.3M(85.5%)
Outstanding117.4M

ⓘ Float data from /shares-float reflects the most recent SEC filing period-end. The weighted average shares (from /income-statement) may differ — this is a normal reporting window difference, not a data error.

FMP /income-statement · /shares-float · SEC EDGAR · USD

About shares outstanding & methodology

Dynavax Technologies Corporation (DVAX) shares outstanding history from 2005 to 2024. Shares outstanding can be defined as the total number of shares held by all shareholders — including institutional investors, retail investors, and company insiders — assuming conversion of all convertible debt, securities, warrants, and options. This metric excludes the company's treasury shares.

Dynavax Technologies Corporation shares outstanding for the fiscal year ending December 31, 2024 were 130.0M, a 1.02% increase year-over-year. Dynavax Technologies Corporation FY 2024 shares outstanding were 130.0M, a +1.02% increase from FY 2023.

Dynavax Technologies Corporation is a leading company operating in the Healthcare sector. The company's share count trajectory — with a 10-year CAGR of +17.3% — is a key signal for investors evaluating capital return policy, EPS accretion, and long-term shareholder value creation.

Figures tie to SEC 10-K/10-Q income statement disclosures and FMP /income-statement · /shares-float where noted.
Market capSplitsEarningsFinancials (Income)Cash on handFree cash flowNet incomePrice history

Frequently asked questions

DVAX shares outstanding · 4 questions

As of December 31, 2024, Dynavax Technologies Corporation (DVAX) has approximately 130.0M basic shares outstanding and 133.3M diluted shares outstanding. This represents a +1.02% year-over-year increase from FY 2023 (128.7M). The increase may reflect equity compensation issuances or secondary offerings.

DVAX shares outstandinghow many shares does DVAX haveDVAX basic shares 2024DVAX diluted shares

▸ Data: FMP /income-statement · /shares-float · SEC EDGAR · weighted average basis · Dynavax Technologies Corporation SEC 10-K & 10-Q filings · US GAAP · Last updated: 2026-06-08